Market Closed -
OTC Markets
11:34:11 31/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.044
USD
|
-11.82%
|
|
-16.19%
|
+11.96%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
102.7
|
6.178
|
5.324
|
5.376
|
3.137
|
Enterprise Value (EV)
1 |
103.5
|
6.686
|
5.861
|
7.688
|
5.344
|
P/E ratio
|
-15.2
x
|
-0.62
x
|
-1.29
x
|
-1.71
x
|
-0.73
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
10,37,17,365
x
|
13,91,36,787
x
|
4,27,83,276
x
|
41,33,91,092
x
|
EV / Revenue
|
-
|
11,22,36,133
x
|
15,31,68,853
x
|
6,11,81,224
x
|
70,41,59,046
x
|
EV / EBITDA
|
-18.2
x
|
-0.85
x
|
-1.85
x
|
-3.51
x
|
-2.61
x
|
EV / FCF
|
-49.9
x
|
4.27
x
|
-3.98
x
|
59.4
x
|
-3.47
x
|
FCF Yield
|
-2%
|
23.4%
|
-25.1%
|
1.68%
|
-28.8%
|
Price to Book
|
394
x
|
-3.26
x
|
-1.76
x
|
-0.92
x
|
-0.38
x
|
Nbr of stocks (in thousands)
|
44,642
|
51,485
|
64,926
|
67,203
|
79,828
|
Reference price
2 |
2.300
|
0.1200
|
0.0820
|
0.0800
|
0.0393
|
Announcement Date
|
29/05/20
|
15/04/21
|
15/04/22
|
15/05/23
|
23/05/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
0.0596
|
0.0383
|
0.1257
|
0.007589
|
EBITDA
1 |
-2.493
|
-5.699
|
-7.884
|
-3.164
|
-2.193
|
-2.047
|
EBIT
1 |
-2.496
|
-5.719
|
-7.918
|
-3.204
|
-2.235
|
-2.081
|
Operating Margin
|
-
|
-
|
-13,291.65%
|
-8,374.2%
|
-1,778.69%
|
-27,419.57%
|
Earnings before Tax (EBT)
1 |
-2.613
|
-6.207
|
-7.965
|
-3.785
|
-3.059
|
-3.953
|
Net income
1 |
-2.613
|
-6.207
|
-7.965
|
-3.785
|
-3.059
|
-3.953
|
Net margin
|
-
|
-
|
-13,371.54%
|
-9,890.66%
|
-2,434.69%
|
-52,092.78%
|
EPS
2 |
-0.0817
|
-0.1511
|
-0.1947
|
-0.0635
|
-0.0468
|
-0.0539
|
Free Cash Flow
1 |
-1.507
|
-2.075
|
1.567
|
-1.472
|
0.1295
|
-1.541
|
FCF margin
|
-
|
-
|
2,631.24%
|
-3,846.55%
|
103.03%
|
-20,304.16%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/04/19
|
29/05/20
|
15/04/21
|
15/04/22
|
15/05/23
|
23/05/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.89
|
0.86
|
0.51
|
0.54
|
2.31
|
2.21
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.3563
x
|
-0.1515
x
|
-0.0644
x
|
-0.1697
x
|
-1.054
x
|
-1.078
x
|
Free Cash Flow
1 |
-1.51
|
-2.08
|
1.57
|
-1.47
|
0.13
|
-1.54
|
ROE (net income / shareholders' equity)
|
808%
|
3,177%
|
941%
|
-1,039%
|
-4,774%
|
164%
|
ROA (Net income/ Total Assets)
|
-593%
|
-302%
|
-304%
|
-92.9%
|
-46%
|
-79.6%
|
Assets
1 |
0.4411
|
2.054
|
2.62
|
4.073
|
6.648
|
4.965
|
Book Value Per Share
2 |
-0.0200
|
0.0100
|
-0.0400
|
-0.0500
|
-0.0900
|
-0.1000
|
Cash Flow per Share
2 |
0
|
0.0100
|
0
|
0
|
0
|
0
|
Capex
1 |
0.48
|
0.37
|
0.06
|
0.39
|
0.04
|
0.01
|
Capex / Sales
|
-
|
-
|
105.03%
|
1,027.4%
|
34.38%
|
66.49%
|
Announcement Date
|
30/04/19
|
29/05/20
|
15/04/21
|
15/04/22
|
15/05/23
|
23/05/24
|
|
1st Jan change
|
Capi.
|
---|
| +11.96% | 4.98M | | -.--% | 339M | | +24.69% | 245M | | +10.31% | 228M | | +36.05% | 177M | | +141.20% | 137M | | -28.57% | 121M | | +32.61% | 120M | | -47.02% | 109M | | -.--% | 87.2M |
Medical Farming
|